Losk, Katya http://orcid.org/0000-0002-5171-2994
Freedman, Rachel A.
Laws, Alison
Kantor, Olga
Mittendorf, Elizabeth A.
Tan-Wasielewski, Zhenying
Trippa, Lorenzo
Lin, Nancy U.
Winer, Eric P.
King, Tari A.
Funding for this research was provided by:
National Cancer Institute (R21CA227615-01A1)
American Cancer Society (125912-MRSG-14-240-01-CPPB)
Susan G. Komen (CCRCR18552788)
Article History
Received: 10 July 2020
Accepted: 5 September 2020
First Online: 16 September 2020
Compliance with ethical standards
:
: RAF reports institutional research funding from Eisai and Puma. EAM reports scientific advisory board participation (and compensation) for Genomic Health/Exact Sciences. NUL reports institutional research funding from Genentech, Pfizer, Merck, Seattle Genetics; and consultant/advisor role for Puma, Seattle Genetics, Daiichi-Sankyo, Denali Therapeutics, California Institute for Regenerative Medicine. EPW reports consultant/advisor role for Genomic Health/Exact Sciences. TK reports speaker’s fees from Genomic Health/Exact Sciences. All other authors report no disclosures.
: As this is a secondary analysis of previously collected data, this study was exempt from review by the Dana-Farber/Harvard Cancer Center Institutional Review Board.